Cephalon's 2007 Results Exceed Full Year Sales and Earning... (s a component of research and develop...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance

Date:2/12/2008

s a component of research and

development or selling, general and administrative, as appropriate.

CEPHALON, INC. AND SUBSIDIARIES

Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

(Unaudited)

Three Months Ended

December 31,

2007 2006

GAAP NET INCOME (LOSS) $44,182 $(4,909)

Cost of sales adjustments 26,306 (1) 20,958 (1)

Research and development adjustments 2,000 (2) 35,500 (2) (7)

Selling, general and administrative

adjustments 11,191 (3) - (7)

Acquired in-process research and

development - 5,000 (5)

Debt exchange expense - 48,122 (6)

Income taxes (18,149)(4) (30,831)(4) (7)

21,348 78,749

ADJUSTED NET INCOME $65,530 $73,840

BASIC ADJUSTED INCOME PER COMMON SHARE $0.98 $1.20

DILUTED ADJUSTED INCOME PER COMMON

SHARE $0.83 $1.00

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING 67,187 61,783

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING-ASSUMING DILUTION 78,734 73,633 Notes to Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

(1) To exclude the on-going amortization of acquired intangible assets.

(2) To exclude charges related to payments for several research and

development collaborations.

(3) To exclude charges related to certain employee
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007

Post Your Comments:

Breaking Biology Technology:Sirius Genomics Announces Change in Leadership 2 MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2 MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3 MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4 Oxford BioTherapeutics Appoints Michael Moore as Chairman 2 Oxford BioTherapeutics Appoints Michael Moore as Chairman 3 Oxford BioTherapeutics Appoints Michael Moore as Chairman 4

[0] Sirius Genomics Announces Change in Leadership [0] MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products [0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics [0] Oxford BioTherapeutics Appoints Michael Moore as Chairman

Other Biology Technology:Real-Time Immuno-PCR on the iCycler iQ System, Rev A 2 Real-Time Immuno-PCR on the iCycler iQ System, Rev A 3 Real-Time Immuno-PCR on the iCycler iQ System, Rev A 4 Real-Time Immuno-PCR on the iCycler iQ System, Rev A 5 Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 2 Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 3 Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 4 Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 5 Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 6 Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 7 Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A 8 Imaging and Analysis of DIGE Product Information Sheet, Rev B 2 Imaging and Analysis of DIGE Product Information Sheet, Rev B 3 Imaging and Analysis of DIGE Product Information Sheet, Rev B 4 Imaging and Analysis of DIGE Product Information Sheet, Rev B 5 Imaging and Analysis of DIGE Product Information Sheet, Rev B 6 Imaging and Analysis of DIGE Product Information Sheet, Rev B 7

Real-Time Immuno-PCR on the iCycler iQ System, Rev A Rapid, Reproducible Real-Time Quantitative RT-PCR Using the iCycler iQ Real-Time PCR Detection System and iQ Supermix, Rev A Imaging and Analysis of DIGE Product Information Sheet, Rev B

Breaking Biology News(10 mins):77 percent of European pigs are castrated without anesthetic 2 Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 2 Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 3 Carnegie Mellon researchers receive grant 2 New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 1 New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 2 New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 3 New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 4 Targeted breast ultrasound can reduce biopsies for women under 40 62404 1 Targeted breast ultrasound can reduce biopsies for women under 40 62404 2 Omnetics Announces Newest Addition to Nano Circular Family 62401 1 Omnetics Announces Newest Addition to Nano Circular Family 62401 2

[0] 77 percent of European pigs are castrated without anesthetic [0] Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide [0] Carnegie Mellon researchers receive grant

Other Biology News:New biofuels process promises to meet all US transportation needs 2 New biofuels process promises to meet all US transportation needs 3 New biofuels process promises to meet all US transportation needs 4 Scripps research team discovers a chemical pathway that causes mice to overeat and gain weight 2

New biofuels process promises to meet all US transportation needs Scripps research team discovers a chemical pathway that causes mice to overeat and gain weight What recognizes what in plant disease resistance?

Biology Products:

EasySep PE Selection Kit, Other, Starter Kit from StemCell Technologies, Inc.Digital Eclipse C1 Plus Modular Confocal System from Nikon Eclipse C1si from Nikon DMBA300 Digital Infinity Compound from Motic Instruments, Inc.